Panmure Gordon reaffirmed their buy rating on shares of Collagen Solutions PLC (LON:COS) in a research note published on Thursday morning. They currently have a GBX 10 ($0.13) price target on the stock.

Separately, Beaufort Securities reaffirmed a buy rating on shares of Collagen Solutions PLC in a report on Tuesday, July 12th.

Shares of Collagen Solutions PLC (LON:COS) opened at 8.375 on Thursday. The company’s market cap is GBX 14.36 million. Collagen Solutions PLC has a 1-year low of GBX 5.00 and a 1-year high of GBX 12.16. The stock has a 50 day moving average price of GBX 8.60 and a 200-day moving average price of GBX 7.11.

In related news, insider Evans,David bought 900,000 shares of the company’s stock in a transaction dated Wednesday, July 6th. The stock was acquired at an average cost of GBX 6 ($0.08) per share, with a total value of £54,000 ($70,486.88).

Collagen Solutions PLC Company Profile

Collagen Solutions plc is a United Kingdom-based holding company. The Company is engaged in supply, development and manufacture of medical grade collagen components and bio materials for use in regenerative medicine, medical devices and in-vitro diagnostics. The Company’s products include CS001, which is a type I Bovine soluble collagen; CS004, which is a type I Acid swollen gel; CS007, which is a titration buffer; CS010, which is a Bovine Dermal fibrous powder; CS013, which is a type I fibrous powder; CS019, which is a type I Bovine soluble collagen; CS022, which is a pulp, and CS028, which is a type I acid soluble collagen.

Receive News & Ratings for Collagen Solutions PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Collagen Solutions PLC and related companies with MarketBeat.com's FREE daily email newsletter.